ParcelBio (YC Winter 2024)

TL;DR: ParcelBio is a Y Combinator Winter 2024 startup Elevated mRNA for transformative medicines., currently active with a team of 6.

Elevated mRNA for transformative medicines.

YC ID
29527
YC Batch
Winter 2024
Status
Active
Team size
6
Industry
Healthcare, Therapeutics
Tags
Gene Therapy, Synthetic Biology, Biotech
YC profile
https://www.ycombinator.com/companies/parcelbio

Last verified:

ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Frequently asked questions

Is ParcelBio a YC (Y Combinator) company?

Yes. ParcelBio was funded by Y Combinator in the Winter 2024 batch. Elevated mRNA for transformative medicines.

What does ParcelBio do?

ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clin…

What YC batch was ParcelBio in?

ParcelBio was part of Y Combinator's Winter 2024 batch.

How big is ParcelBio?

ParcelBio has a team of 6 people according to Y Combinator's directory.

Is ParcelBio still active?

ParcelBio is currently listed as Active with a team of 6 in Y Combinator's directory.

More YC Winter 2024 companies

More Healthcare YC startups

Explore related YC hubs

Loading interactive view…